Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A.
(2004). Diabetes mellitus and risk of alzheimer disease and decline
in cognitive function. Archives of Neurology, 61(5), 661–666. https://
doi.org/10.1001/archneur.61.5.661
Ba, X., & Boldogh, I. (2018). 8-Oxoguanine DNA glycosylase 1: Beyond
repair of the oxidatively modified base lesions. Redox Biology, 14,
669–678. https://doi.org/10.1016/j.redox.2017.11.008
Barron, A. M., Rosario, E. R., Elteriefi, R., & Pike, C. J. (2013). Sex-specific
effects of high fat diet on indices of metabolic syndrome in 3xTg-AD
mice: Implications for Alzheimer's disease. PLoS ONE, 8, e78554.
https://doi.org/10.1371/journal.pone.0078554
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox,
N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., Holtzman,
D. M., Santacruz, A., Buckles, V., Oliver, A., Moulder, K., Aisen, P. S.,
Ghetti, B., Klunk, W. E., McDade, E., … Morris, J. C. (2012). Clinical
and biomarker changes in dominantly inherited Alzheimer's disease. New England Journal of Medicine, 367(9), 795–8 04. https://doi.
org/10.1056/NEJMoa1202753
Bracko, O., Vinarcsik, L. K., Cruz Hernández, J. C., Ruiz-Uribe, N. E.,
Haft-Javaherian, M., Falkenhain, K., Ramanauskaite, E. M., Ali, M.,
Mohapatra, A., Swallow, M. A., Njiru, B. N., Muse, V., Michelucci,
P. E., Nishimura, N., & Schaffer, C. B. (2020). High fat diet worsens Alzheimer's disease-related behavioral abnormalities and neuropathology in APP/PS1 mice, but not by synergistically decreasing cerebral blood flow. Scientific Reports, 10, 9884. https://doi.
org/10.1038/s41598-020-65908-y
Buxbaum, J. N., Ye, Z., Reixach, N., Friske, L., Levy, C., Das, P., Golde, T.,
Masliah, E., Roberts, A. R., & Bartfai, T. (2008). Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects
of A toxicity. Proceedings of the National Academy of Sciences, 105(7),
2681–2686. https://doi.org/10.1073/pnas.0712197105
Castillo, E., Leon, J., Mazzei, G., Abolhassani, N., Haruyama, N., Saito, T.,
Saido, T., Hokama, M., Iwaki, T., Ohara, T., Ninomiya, T., Kiyohara,
Y., Sakumi, K., LaFerla, F. M., & Nakabeppu, Y. (2017). Comparative
profiling of cortical gene expression in Alzheimer's disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation. Scientific Reports, 7, 17762. https://doi.
org/10.1038/s41598-017-17999-3
Choi, S. H., Leight, S. N., Lee, V. M. Y., Li, T., Wong, P. C., Johnson, J.
A., Saraiva, M. J., & Sisodia, S. S. (2007). Accelerated A deposition in APPswe/PS1 E9 mice with hemizygous deletions of TTR
(Transthyretin). Journal of Neuroscience, 27, 7006–7010. https://doi.
org/10.1523/JNEUROSCI.1919-07.2007
Copps, K. D., & White, M. F. (2012). Regulation of insulin sensitivity by
serine/threonine phosphorylation of insulin receptor substrate
proteins IRS1 and IRS2. Diabetologia, 55, 2565–2582. https://doi.
org/10.1007/s00125-012-2644-8
Cordner, Z. A., & Tamashiro, K. L. K. (2015). Effects of high-fat diet exposure on learning & memory. Physiology & Behavior, 152, 363–371.
https://doi.org/10.1016/j.physbeh.2015.06.008
de la Monte, S. M. (2014). Type 3 diabetes is sporadic Alzheimer׳s disease: Mini-review. European Neuropsychopharmacology, 24, 1954–
1960. https://doi.org/10.1016/j.euroneuro.2014.06.008
Elhaik Goldman, S., Goez, D., Last, D., Naor, S., Liraz Zaltsman, S., Sharvit-
Ginon, I., Atrakchi-Baranes, D., Shemesh, C., Twitto-Greenberg,
R., Tsach, S., Lotan, R., Leikin-Frenkel, A., Shish, A., Mardor, Y.,
Schnaider Beeri, M., & Cooper, I. (2018). High-fat diet protects the
blood-brain barrier in an Alzheimer's disease mouse model. Aging
Cell, 17, e12818. https://doi.org/10.1111/acel.12818
Ettcheto, M., Petrov, D., Pedrós, I., Alva, N., Carbonell, T., Beas-Zarate,
C., Pallas, M., Auladell, C., Folch, J., & Camins, A. (2016). Evaluation
of neuropathological effects of a high-fat diet in a presymptomatic
Alzheimer's disease stage in APP/PS1 mice. Journal of Alzheimer's
Disease, 54, 233–251. https://doi.org/10.3233/JAD-160150
Gale, S. A., Acar, D., & Daffner, K. R. (2018). Dementia. American
Journal of Medicine, 131(10), 1161–1169. https://doi.org/10.1016/j.
amjmed.2018.01.022
Ghadami, S. A., Chia, S., Ruggeri, F. S., Meisl, G., Bemporad, F., Habchi,
J., Cascella, R., Dobson, C. M., Vendruscolo, M., Knowles, T. P. J., &
Chiti, F. (2020). Transthyretin inhibits primary and secondary nucleations of amyloid-β peptide aggregation and reduces the toxicity of its oligomers. Biomacromolecules, 21, 1112–1125. https://doi.
org/10.1021/acs.biomac.9b01475
Haass, C., & Selkoe, D. J. (2007). Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid β-peptide. Nature
Reviews Molecular Cell Biology, 8, 101–112. https://doi.org/10.1038/
nrm2101
Haruyama, N., Sakumi, K., Katogi, A., Tsuchimoto, D., De Luca, G.,
Bignami, M., & Nakabeppu, Y. (2019). 8-Oxoguanine accumulation
in aged female brain impairs neurogenesis in the dentate gyrus and
major island of Calleja, causing sexually dimorphic phenotypes.
Progress in Neurobiology, 180, 101613. https://doi.org/10.1016/j.
pneurobio.2019.04.002
16 of 17 Heydemann, A. (2016). An overview of murine high fat diet as a model
for type 2 diabetes mellitus. Journal of Diabetes Research, 2016,
2902351. https://doi.org/10.1155/2016/2902351
Kanoski, S. E., & Davidson, T. L. (2011). Western diet, cognitive impairment and hippocampal function. Physiology & Behavior, 103, 59–68.
https://doi.org/10.1016/j.physbeh.2010.12.003
Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., &
Younkin, S. G. (2001). Age-dependent changes in brain, CSF, and
plasma amyloid β protein in the Tg2576 transgenic mouse model of
Alzheimer's disease. Journal of Neuroscience, 21, 372–381. https://
doi.org/10.1523/jneurosci.21-02-0 0372.2001
Kayed, R., & Lasagna-Reeves, C. A. (2013). Molecular mechanisms of amyloid oligomers toxicity. Journal of Alzheimer's Disease, 33, S67–S78.
https://doi.org/10.3233/JAD-2012-129001
Knight, E. M., Martins, I. V. A., Gümüsgöz, S., Allan, S. M., & Lawrence,
C. B. (2014). High-fat diet-induced memory impairment in triple-
transgenic Alzheimer's disease (3xTgAD) mice isindependent of
changes in amyloid and tau pathology. Neurobiology of Aging, 35,
1821–1832. https://doi.org/10.1016/j.neurobiolaging.2014.02.010
Li, X., & Buxbaum, J. N. (2011). Transthyretin and the brain re-visited:
Is neuronal synthesis of transthyretin protective in Alzheimer's
disease? Molecular Neurodegeneration, 6, 79. https://doi.
org/10.1186/1750-1326-6-79
Masuda, A., Kobayashi, Y., Kogo, N., Saito, T., Saido, T. C., & Itohara, S.
(2016). Cognitive deficits in single App knock-in mouse models.
Neurobiology of Learning and Memory, 135, 73–
82. https://doi.
org/10.1016/j.nlm.2016.07.001
Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y.,
Sekita, A., Suzuki, S. O., Kanba, S., Kiyohara, Y., & Iwaki, T. (2010).
Insulin resistance is associated with the pathology of Alzheimer
disease: The Hisayama study. Neurology, 75, 764–770. https://doi.
org/10.1212/WNL.0b013e3181eee25f
Nakabeppu, Y. (2019). Molecular pathophysiology of insulin depletion, mitochondrial dysfunction, and oxidative stress in
Alzheimer's disease brain. In Y. Nakabeppu & T. Ninomiya (Eds.),
Diabetes Mellitus. Advances in Experimental Medicine and Biology
(Vol. 1128, pp. 27–
4 4). Springer New York LLC. https://doi.
org/10.1007/978-981-13-3540-2_3
Neves, G., Cooke, S. F., & Bliss, T. V. P. (2008). Synaptic plasticity, memory and the hippocampus: a neural network approach to causality.
Nature Reviews Neuroscience, 9, 65–75. https://doi.org/10.1038/
nrn2303
Ninomiya, T. (2014). Diabetes mellitus and dementia. Current Diabetes
Reports, 14, 487. https://doi.org/10.1007/s11892- 014- 0 487-z
Ninomiya, T. (2019). Epidemiological evidence of the relationship between diabetes and dementia. In Y. Nakabeppu & T. Ninomiya
(Eds.), Diabetes Mellitus. Advances in Experimental Medicine and
Biology (Vol. 1128, pp. 13–25). Springer New York LLC. https://doi.
org/10.1007/978-981-13-3540-2_2
Oka, S., Leon, J., Sakumi, K., Ide, T., Kang, D., LaFerla, F. M., & Nakabeppu,
Y. (2016). Human mitochondrial transcriptional factor A breaks
the mitochondria-mediated vicious cycle in Alzheimer's disease.
Scientific Reports, 6, 37889. https://doi.org/10.1038/srep37889
Oliveira, S. M., Ribeiro, C. A., Cardoso, I., & Saraiva, M. J. (2011). Gender-
dependent transthyretin modulation of brain amyloid-
β Levels:
Evidence from a mouse model of Alzheimer's disease. Journal
of Alzheimer's Disease, 27, 429–
439. https://doi.org/10.3233/
JAD-2011-110488
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002). Type 2 diabetes, APOE
gene, and the risk for dementia and related pathologies: The
Honolulu-A sia aging study. Diabetes, 51, 1256–1262. https://doi.
org/10.2337/diabetes.51.4.1256
Sah, S. K., Lee, C., Jang, J. H., & Park, G. H. (2017). Effect of high-fat diet on
cognitive impairment in triple-transgenic mice model of Alzheimer's
MAZZEI et al.
disease. Biochemical and Biophysical Research Communications, 493,
731–736. https://doi.org/10.1016/j.bbrc.2017.08.122
Saito, T., Matsuba, Y., Mihira, N., Takano, J., Nilsson, P., Itohara, S., Iwata,
N., & Saido, T. C. (2014). Single App knock-in mouse models of
Alzheimer's disease. Nature Neuroscience, 17, 661–663. https://doi.
org/10.1038/nn.3697
Salas, I. H., Weerasekera, A., Ahmed, T., Callaerts-Vegh, Z., Himmelreich,
U., D'Hooge, R., Balschun, D., Saido, T. C., De Strooper, B., & Dotti,
C. G. (2018). High fat diet treatment impairs hippocampal long-term
potentiation without alterations of the core neuropathological features of Alzheimer disease. Neurobiology of Disease, 113, 82–96.
https://doi.org/10.1016/j.nbd.2018.02.001
Schoenfeld, T. J., McCausland, H. C., Morris, H. D., Padmanaban, V., &
Cameron, H. A. (2017). Stress and loss of adult neurogenesis differentially reduce hippocampal volume. Biological Psychiatry, 82, 914–
923. https://doi.org/10.1016/j.biopsych.2017.05.013
Selkoe, D. J. (2000). Toward a comprehensive theory for Alzheimer's
disease. Hypothesis: Alzheimer's disease is caused by the cerebral
accumulation and cytotoxicity of amyloid β-protein. Annals of the
New York Academy of Sciences, 924, 17–25. https://doi.org/10.1111/
j.1749-6632.2000.tb05554.x
Sharma, M., Khan, S., Rahman, S., & Singh, L. R. (2019). The extracellular
protein, transthyretin is an oxidative stress biomarker. Frontiers in
Physiology, 10, 1–8. https://doi.org/10.3389/fphys.2019.00005
Stein, T. D., & Johnson, J. A. (2002). Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of
cell survival pathways. The Journal of Neuroscience, 22, 7380–7388.
https://doi.org/10.1523/JNEUROSCI.22-17-07380.2002
Thal, D. R., Walter, J., Saido, T. C., & Fändrich, M. (2015). Neuropathology
and biochemistry of Aβ and its aggregates in Alzheimer's disease.
Acta Neuropathologica, 129, 167–
182. https://doi.org/10.1007/
s00401-014-1375-y
Vancamp, P., Gothié, J.-D., Luongo, C., Sébillot, A., Le Blay, K., Butruille,
L., Pagnin, M., Richardson, S. J., Demeneix, B. A., & Remaud, S.
(2019). Gender-
specific effects of transthyretin on neural stem
cell fate in the subventricular zone of the adult mouse. Scientific
Reports, 9, 1–14. https://doi.org/10.1038/s41598-019-56156-w
Vandal, M., White, P. J., Tremblay, C., St-Amour, I., Chevrier, G., Emond,
V., Lefranc¸ois, D., Virgili, J., Planel, E., Giguere, Y., Marette, A., &
Calon, F. (2014). Insulin reverses the high-fat diet-induced increase
in brain Aβ and improves memory in an animal model of Alzheimer
disease. Diabetes, 63, 4291–
4301. https://doi.org/10.2337/
db14-0375
Velayudhan, L., Killick, R., Hye, A., Kinsey, A., Güntert, A., Lynham, S.,
Ward, M., Leung, R., Lourdusamy, A., To, A. W. M., Powell, J., &
Lovestone, S. (2012). Plasma transthyretin as a candidate marker
for Alzheimer's disease. Journal of Alzheimer's Disease, 28, 369–375.
https://doi.org/10.3233/JAD-2011-110611
Vieira, M., & Saraiva, M. J. (2014). Transthyretin: A multifaceted protein. BioMolecular Concepts, 5, 45–54. https://doi.org/10.1515/
bmc-2013-0 038
Wakabayashi, T., Yamaguchi, K., Matsui, K., Sano, T., Kubota, T.,
Hashimoto, T., Mano, A., Yamada, K., Matsuo, Y., Kubota, N.,
Kadowaki, T., & Iwatsubo, T. (2019). Differential effects of diet- and
genetically-induced brain insulin resistance on amyloid pathology in
a mouse model of Alzheimer's disease. Molecular Neurodegeneration,
14, 15. https://doi.org/10.1186/s13024-019-0315-7
Walker, J. M., Dixit, S., Saulsberry, A. C., May, J. M., & Harrison, F. E.
(2017). Reversal of high fat diet-
induced obesity improves glucose tolerance, inflammatory response, β-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of
Alzheimer's disease. Neurobiology of Disease, 100, 87–98. https://
doi.org/10.1016/j.nbd.2017.01.004
17 of 17
MAZZEI et al.
Yeh, C. W., Yeh, S. H. H., Shie, F. S., Lai, W. S., Liu, H. K., Tzeng, T. T.,
Tsay, H. J., & Shiao, Y. J. (2015). Impaired cognition and cerebral
glucose regulation are associated with astrocyte activation in the
parenchyma of metabolically stressed APPswe/PS1dE9 mice.
Neurobiology of Aging, 36, 2984–2994. https://doi.org/10.1016/j.
neurobiolaging.2015.07.022
S U P P O R T I N G I N FO R M AT I O N
Additional supporting information may be found online in the
Supporting Information section.
How to cite this article: Mazzei, G., Ikegami, R., Abolhassani,
N., Haruyama, N., Sakumi, K., Saito, T., Saido, T. C., &
Nakabeppu, Y. (2021). A high-fat diet exacerbates the
Alzheimer's disease pathology in the hippocampus of the
AppNL−F/NL−F knock-in mouse model. Aging Cell, 00, e13429.
https://doi.org/10.1111/acel.13429
...